|
OxyContin’s makers delayed the reckoning for their role in the opioid crisis by funding think tanks, placing friendly experts on leading outlets, and deterring or challenging negative coverage.
|
|
|
The Big Story
Tue. Nov 19, 2019
|
 |
|
OxyContin’s makers delayed the reckoning for their role in the opioid crisis by funding think tanks, placing friendly experts on leading outlets, and deterring or challenging negative coverage.
by David Armstrong
|
|
| |
|
More From This Investigation
|
Downplaying its role in the opioid epidemic, Purdue Pharma has embraced a federal statistic showing it was a minor player in the pain pill market. But when we took drug potency into account, Purdue’s importance soared.
by David Armstrong and Jeff Ernsthausen
|
Sackler testified in 2015 in a lawsuit brought by Kentucky against his family’s company, Purdue Pharma, which makes the painkiller OxyContin. We published the transcript in February. Now you can see the video.
by David Armstrong
|
As OxyContin addiction spurred a national nightmare, a member of the family that has reaped billions of dollars from the painkiller boasted that sales exceeded his “fondest dreams,” according to a secret court document obtained by ProPublica.
by David Armstrong
|
Secret portions of a lawsuit allege that Purdue Pharma, controlled by the Sackler family, considered capitalizing on the addiction treatment boom — while going to extreme lengths to boost sales of its controversial opioid.
by David Armstrong
|
|
A previous Big Story email misstated the names of two reporters. They are Lakeidra Chavis and Jennifer Smith Richards, not Lakeidra Davis and Jennifer Smith.
|
|
|
